Transaction in Own Shares

Fidelity Emerging Markets Limited repurchased and cancelled 99,999 ordinary shares on 9 January 2026 at an average price of 1,099.160 GBp (range 1,094.000–1,100.000 GBp). After the transaction issued share capital stands at 53,195,667, treasury holdings at 9,025,940 and total voting rights at 44,169,728; the repurchase equals roughly 0.19% of issued shares, implying only a marginal reduction in share count and limited EPS accretion. The move is a routine buyback/cancellation with minimal market impact but is slightly positive for remaining shareholders' per-share metrics.

Analysis

Market structure: The buyback (99,999 shares at an average 1,099.16 GBp = ~£1.10m) is tiny—~0.19% of issued share capital—but incremental cancellation mechanically raises NAV per share and supports the secondary market. Primary beneficiaries are incumbent holders and discount-arbitrageurs; index/ETF providers (EEM, VWO) and EM underlying issuers see no material change. With 9.03m shares in treasury (~17% of issued) the company already has a constrained free float, so even small buybacks can widen intraday moves but are unlikely to shift EM asset pricing or FX beyond idiosyncratic effects.

Risk assessment: Tail risks include a sudden EM NAV shock (e.g., China/EM growth surprise) that turns buybacks into value-destructive liquidity sales, or regulatory scrutiny of buybacks; both are low probability but high impact. Immediate (days) effect: modest positive tone and possible 0–2% tightening of discount; short-term (1–3 months): discount compression of 0–5% if buybacks continue; long-term only meaningful if buybacks scale to >1% of issued within 6 months. Hidden dependency: large treasury stock reduces liquidity and amplifies volatility—monitor bid/ask spreads and daily ADV relative to position size.

Trade implications: Direct: consider a tactical long (1–3% portfolio) in Fidelity Emerging Markets Limited (LSE-listed) if discount to NAV >6%, target capture 6–15% over 1–3 months; pair trade: long FEM stock, short-market exposure via EEM (size to neutralize beta) to isolate discount narrowing. Options: if liquid, buy 3-month call spread or sell puts struck ~8–12% OTM for premium if comfortable with assignment; set stop-loss at 8% absolute or if discount widens >10%.

Contrarian angles: The market may overrate this as a major capital-return programme; it’s underdone—one-off, tiny buyback amid 17% treasury holdings. Historical parallels (UK investment trusts) show discounts only narrow materially after sustained repurchases >1–3% of free float. Unintended consequence: shrinking tradable float may increase execution costs for larger funds; watch for escalation to a meaningful program or an explanation that buybacks are opportunistic capital management rather than a signal of undervaluation.

Key Decisions for Investors

• Establish a tactical long position (1–3% of portfolio) in Fidelity Emerging Markets Limited (LSE) if the discount to reported NAV is >6%; target a 6–15% return via discount compression within 1–3 months, stop-loss at -8% absolute or if discount widens >10%.
• Implement a pair trade: long Fidelity Emerging Markets Ltd (size X) and short iShares MSCI Emerging Markets ETF (EEM) or Vanguard FTSE Emerging Markets ETF (VWO) (size scaled to neutralize beta) to capture discount tightening while hedging EM beta over 1–3 months.
• If options are available/liquid on the trust, buy a 3-month call spread (e.g., 0–12% upside) or sell 3-month cash-secured puts 8–12% OTM to collect premium; allocate no more than 0.5–1% portfolio risk to options exposure.
• Monitor three specific catalysts over the next 60 days before scaling: (1) further buyback announcements >1% of issued in 3 months, (2) monthly NAV movements >5% negative (stop and reassess), and (3) bid/ask spread widening >30% vs 3-month average (indicates deteriorating liquidity).